Unresolved disorder model. using A ATOM 161 N AILE 22 7.571 3.875 23.951 0.50 9.18 N Unresolved disorder model. using A ATOM 162 N BILE 22 7.570 3.876 23.951 0.50 9.26 N Unresolved disorder model. using A ATOM 163 CA AILE 22 6.301 3.789 24.671 0.50 8.96 C Unresolved disorder model. using A ATOM 164 CA BILE 22 6.297 3.791 24.668 0.50 9.11 C Unresolved disorder model. using A ATOM 165 C AILE 22 5.678 2.389 24.561 0.50 8.71 C Unresolved disorder model. using A ATOM 166 C BILE 22 5.672 2.392 24.556 0.50 8.81 C Unresolved disorder model. using A ATOM 167 O AILE 22 4.759 2.057 25.307 0.50 8.48 O Unresolved disorder model. using A ATOM 168 O BILE 22 4.749 2.062 25.296 0.50 8.58 O Unresolved disorder model. using A ATOM 169 CB AILE 22 5.313 4.889 24.206 0.50 9.18 C Unresolved disorder model. using A ATOM 170 CB BILE 22 5.307 4.904 24.210 0.50 9.47 C Unresolved disorder model. using A ATOM 171 CG1AILE 22 4.253 5.166 25.281 0.50 9.39 C Unresolved disorder model. using A ATOM 172 CG1BILE 22 4.219 5.166 25.263 0.50 10.07 C Unresolved disorder model. using A ATOM 173 CG2AILE 22 4.690 4.532 22.852 0.50 9.17 C Unresolved disorder model. using A ATOM 174 CG2BILE 22 4.688 4.574 22.855 0.50 9.44 C Unresolved disorder model. using A ATOM 175 CD1AILE 22 3.415 6.396 25.025 0.50 9.07 C Unresolved disorder model. using A ATOM 176 CD1BILE 22 4.703 5.904 26.496 0.50 11.21 C Unresolved disorder model. using A ATOM 260 N AASP 34 -9.383 -10.765 31.606 0.50 8.72 N Unresolved disorder model. using A ATOM 261 N BASP 34 -9.385 -10.744 31.611 0.50 8.80 N Unresolved disorder model. using A ATOM 262 CA AASP 34 -9.697 -11.840 32.530 0.50 9.48 C Unresolved disorder model. using A ATOM 263 CA BASP 34 -9.693 -11.763 32.610 0.50 9.60 C Unresolved disorder model. using A ATOM 264 C AASP 34 -11.086 -11.560 33.090 0.50 9.91 C Unresolved disorder model. using A ATOM 265 C BASP 34 -11.123 -11.496 33.065 0.50 10.00 C Unresolved disorder model. using A ATOM 266 O AASP 34 -11.269 -10.671 33.926 0.50 10.22 O Unresolved disorder model. using A ATOM 267 O BASP 34 -11.375 -10.549 33.816 0.50 10.24 O Unresolved disorder model. using A ATOM 268 CB AASP 34 -8.640 -11.940 33.629 0.50 9.77 C Unresolved disorder model. using A ATOM 269 CB BASP 34 -8.699 -11.643 33.779 0.50 10.06 C Unresolved disorder model. using A ATOM 270 CG AASP 34 -8.799 -13.180 34.483 0.50 10.20 C Unresolved disorder model. using A ATOM 271 CG BASP 34 -8.917 -12.683 34.881 0.50 10.39 C Unresolved disorder model. using A ATOM 272 OD1AASP 34 -8.579 -14.298 33.967 0.50 11.29 O Unresolved disorder model. using A ATOM 273 OD1BASP 34 -7.946 -12.964 35.616 0.50 11.93 O Unresolved disorder model. using A ATOM 274 OD2AASP 34 -9.135 -13.031 35.675 0.50 11.19 O Unresolved disorder model. using A ATOM 275 OD2BASP 34 -10.038 -13.205 35.041 0.50 9.77 O Unresolved disorder model. using A ATOM 371 N ALEU 47 -23.715 2.204 26.359 0.50 13.62 N Unresolved disorder model. using A ATOM 372 N BLEU 47 -23.662 2.198 26.395 0.50 13.79 N Unresolved disorder model. using A ATOM 373 CA ALEU 47 -22.977 2.811 25.261 0.50 12.95 C Unresolved disorder model. using A ATOM 374 CA BLEU 47 -23.033 2.824 25.248 0.50 13.29 C Unresolved disorder model. using A ATOM 375 C ALEU 47 -23.932 3.388 24.209 0.50 12.75 C Unresolved disorder model. using A ATOM 376 C BLEU 47 -24.091 3.541 24.431 0.50 12.83 C Unresolved disorder model. using A ATOM 377 O ALEU 47 -24.877 2.713 23.785 0.50 12.79 O Unresolved disorder model. using A ATOM 378 O BLEU 47 -25.253 3.128 24.390 0.50 12.43 O Unresolved disorder model. using A ATOM 379 CB ALEU 47 -22.044 1.773 24.637 0.50 13.04 C Unresolved disorder model. using A ATOM 380 CB BLEU 47 -22.326 1.791 24.371 0.50 13.71 C Unresolved disorder model. using A ATOM 381 CG ALEU 47 -21.008 2.228 23.615 0.50 12.81 C Unresolved disorder model. using A ATOM 382 CG BLEU 47 -20.931 1.307 24.764 0.50 14.09 C Unresolved disorder model. using A ATOM 383 CD1ALEU 47 -19.927 3.071 24.277 0.50 12.36 C Unresolved disorder model. using A ATOM 384 CD1BLEU 47 -20.458 0.289 23.748 0.50 14.71 C Unresolved disorder model. using A ATOM 385 CD2ALEU 47 -20.400 1.018 22.931 0.50 12.72 C Unresolved disorder model. using A ATOM 386 CD2BLEU 47 -19.936 2.459 24.887 0.50 14.38 C Unresolved disorder model. using A ATOM 700 N AARG 89 -16.085 11.253 17.594 0.50 8.58 N Unresolved disorder model. using A ATOM 701 N BARG 89 -16.054 11.210 17.601 0.50 8.60 N Unresolved disorder model. using A ATOM 702 CA AARG 89 -16.463 11.100 16.188 0.50 8.51 C Unresolved disorder model. using A ATOM 703 CA BARG 89 -16.462 11.117 16.211 0.50 8.54 C Unresolved disorder model. using A ATOM 704 C AARG 89 -15.755 9.950 15.511 0.50 7.83 C Unresolved disorder model. using A ATOM 705 C BARG 89 -15.751 9.985 15.478 0.50 7.86 C Unresolved disorder model. using A ATOM 706 O AARG 89 -14.535 9.815 15.623 0.50 7.41 O Unresolved disorder model. using A ATOM 707 O BARG 89 -14.524 9.879 15.543 0.50 7.44 O Unresolved disorder model. using A ATOM 708 CB AARG 89 -16.132 12.365 15.405 0.50 9.00 C Unresolved disorder model. using A ATOM 709 CB BARG 89 -16.156 12.445 15.533 0.50 9.05 C Unresolved disorder model. using A ATOM 710 CG AARG 89 -17.129 13.471 15.558 0.50 10.00 C Unresolved disorder model. using A ATOM 711 CG BARG 89 -16.891 12.674 14.247 0.50 10.16 C Unresolved disorder model. using A ATOM 712 CD AARG 89 -16.707 14.664 14.735 0.50 11.75 C Unresolved disorder model. using A ATOM 713 CD BARG 89 -16.697 14.096 13.772 0.50 11.55 C Unresolved disorder model. using A ATOM 714 NE AARG 89 -17.445 15.868 15.106 0.50 13.29 N Unresolved disorder model. using A ATOM 715 NE BARG 89 -17.373 15.077 14.618 0.50 13.23 N Unresolved disorder model. using A ATOM 716 CZ AARG 89 -17.100 17.097 14.737 0.50 14.18 C Unresolved disorder model. using A ATOM 717 CZ BARG 89 -17.278 16.395 14.464 0.50 13.60 C Unresolved disorder model. using A ATOM 718 NH1AARG 89 -16.028 17.288 13.983 0.50 14.30 N Unresolved disorder model. using A ATOM 719 NH1BARG 89 -16.535 16.910 13.491 0.50 13.73 N Unresolved disorder model. using A ATOM 720 NH2AARG 89 -17.828 18.136 15.121 0.50 14.71 N Unresolved disorder model. using A ATOM 721 NH2BARG 89 -17.930 17.203 15.285 0.50 13.53 N Unresolved disorder model. using A ATOM 912 CA ALYS 113 -8.066 -15.609 20.639 0.50 7.06 C Unresolved disorder model. using A ATOM 913 CA BLYS 113 -8.073 -15.599 20.649 0.50 7.12 C Unresolved disorder model. using A ATOM 916 CB ALYS 113 -6.772 -16.024 19.937 0.50 7.39 C Unresolved disorder model. using A ATOM 917 CB BLYS 113 -6.741 -15.956 19.980 0.50 7.50 C Unresolved disorder model. using A ATOM 918 CG ALYS 113 -5.501 -15.745 20.703 0.50 7.88 C Unresolved disorder model. using A ATOM 919 CG BLYS 113 -5.521 -15.540 20.776 0.50 8.37 C Unresolved disorder model. using A ATOM 920 CD ALYS 113 -4.293 -16.298 19.953 0.50 9.34 C Unresolved disorder model. using A ATOM 921 CD BLYS 113 -4.245 -16.177 20.252 0.50 10.14 C Unresolved disorder model. using A ATOM 922 CE ALYS 113 -2.978 -15.805 20.542 0.50 10.21 C Unresolved disorder model. using A ATOM 923 CE BLYS 113 -3.037 -15.681 21.029 0.50 11.35 C Unresolved disorder model. using A ATOM 924 NZ ALYS 113 -2.655 -16.448 21.848 0.50 10.57 N Unresolved disorder model. using A ATOM 925 NZ BLYS 113 -1.772 -16.305 20.555 0.50 12.28 N Unresolved disorder model. using A ATOM 1116 N APRO 138 -4.515 11.910 26.777 0.50 8.62 N Unresolved disorder model. using A ATOM 1117 N BPRO 138 -4.583 11.935 26.780 0.50 8.52 N Unresolved disorder model. using A ATOM 1118 CA APRO 138 -4.895 10.647 27.418 0.50 8.78 C Unresolved disorder model. using A ATOM 1119 CA BPRO 138 -4.885 10.643 27.404 0.50 8.70 C Unresolved disorder model. using A ATOM 1120 C APRO 138 -6.319 10.188 27.099 0.50 8.57 C Unresolved disorder model. using A ATOM 1121 C BPRO 138 -6.348 10.201 27.267 0.50 8.54 C Unresolved disorder model. using A ATOM 1122 O APRO 138 -6.561 8.984 26.986 0.50 8.89 O Unresolved disorder model. using A ATOM 1123 O BPRO 138 -6.646 9.024 27.467 0.50 8.90 O Unresolved disorder model. using A ATOM 1124 CB APRO 138 -4.762 10.960 28.910 0.50 9.14 C Unresolved disorder model. using A ATOM 1125 CB BPRO 138 -4.524 10.873 28.872 0.50 8.93 C Unresolved disorder model. using A ATOM 1126 CG APRO 138 -3.738 12.024 28.971 0.50 9.27 C Unresolved disorder model. using A ATOM 1127 CG BPRO 138 -4.691 12.332 29.066 0.50 9.03 C Unresolved disorder model. using A ATOM 1128 CD APRO 138 -3.988 12.876 27.761 0.50 8.80 C Unresolved disorder model. using A ATOM 1129 CD BPRO 138 -4.250 12.962 27.786 0.50 8.85 C Unresolved disorder model. using A ATOM 1222 CA ASER 152 -22.365 -17.792 9.724 0.50 9.17 C Unresolved disorder model. using A ATOM 1223 CA BSER 152 -22.395 -17.759 9.759 0.50 9.16 C Unresolved disorder model. using A ATOM 1226 CB ASER 152 -23.795 -17.623 10.241 0.50 9.83 C Unresolved disorder model. using A ATOM 1227 CB BSER 152 -23.757 -17.465 10.384 0.50 9.80 C Unresolved disorder model. using A ATOM 1228 OG ASER 152 -23.852 -16.650 11.266 0.50 11.09 O Unresolved disorder model. using A ATOM 1229 OG BSER 152 -24.365 -18.650 10.858 0.50 11.19 O Unresolved disorder model. using A ATOM 1319 CA AASP 165 -9.909 -7.313 -4.784 0.50 12.61 C Unresolved disorder model. using A ATOM 1320 CA BASP 165 -9.884 -7.318 -4.766 0.50 12.69 C Unresolved disorder model. using A ATOM 1323 CB AASP 165 -10.786 -8.129 -5.741 0.50 13.19 C Unresolved disorder model. using A ATOM 1324 CB BASP 165 -10.720 -8.176 -5.714 0.50 13.25 C Unresolved disorder model. using A ATOM 1325 CG AASP 165 -10.816 -9.611 -5.397 0.50 14.31 C Unresolved disorder model. using A ATOM 1326 CG BASP 165 -11.671 -7.351 -6.556 0.50 14.55 C Unresolved disorder model. using A ATOM 1327 OD1AASP 165 -9.901 -10.093 -4.698 0.50 15.60 O Unresolved disorder model. using A ATOM 1328 OD1BASP 165 -12.649 -6.806 -6.002 0.50 16.33 O Unresolved disorder model. using A ATOM 1329 OD2AASP 165 -11.757 -10.299 -5.843 0.50 16.27 O Unresolved disorder model. using A ATOM 1330 OD2BASP 165 -11.441 -7.250 -7.781 0.50 15.67 O Unresolved disorder model. using A ATOM 1331 N ASER 166 -10.047 -4.923 -5.218 0.50 11.81 N Unresolved disorder model. using A ATOM 1332 N BSER 166 -10.066 -4.930 -5.227 0.50 12.22 N Unresolved disorder model. using A ATOM 1333 CA ASER 166 -9.678 -3.671 -5.871 0.50 11.28 C Unresolved disorder model. using A ATOM 1334 CA BSER 166 -9.702 -3.660 -5.851 0.50 12.07 C Unresolved disorder model. using A ATOM 1335 C ASER 166 -8.680 -2.847 -5.056 0.50 10.86 C Unresolved disorder model. using A ATOM 1336 C BSER 166 -8.577 -2.940 -5.109 0.50 11.34 C Unresolved disorder model. using A ATOM 1337 O ASER 166 -8.235 -1.790 -5.508 0.50 10.82 O Unresolved disorder model. using A ATOM 1338 O BSER 166 -7.931 -2.053 -5.671 0.50 11.58 O Unresolved disorder model. using A ATOM 1339 CB ASER 166 -10.923 -2.839 -6.177 0.50 11.46 C Unresolved disorder model. using A ATOM 1340 CB BSER 166 -10.920 -2.740 -5.956 0.50 12.52 C Unresolved disorder model. using A ATOM 1341 OG ASER 166 -11.467 -2.290 -4.991 0.50 10.12 O Unresolved disorder model. using A ATOM 1342 OG BSER 166 -11.881 -3.262 -6.857 0.50 13.63 O Unresolved disorder model. using A ATOM 1380 N ALYS 172 -3.263 1.234 -2.444 0.50 10.09 N Unresolved disorder model. using A ATOM 1381 N BLYS 172 -3.267 1.235 -2.433 0.50 10.09 N Unresolved disorder model. using A ATOM 1382 CA ALYS 172 -4.470 1.249 -3.262 0.50 10.10 C Unresolved disorder model. using A ATOM 1383 CA BLYS 172 -4.472 1.244 -3.252 0.50 10.09 C Unresolved disorder model. using A ATOM 1384 C ALYS 172 -5.683 1.662 -2.435 0.50 9.77 C Unresolved disorder model. using A ATOM 1385 C BLYS 172 -5.683 1.666 -2.429 0.50 9.76 C Unresolved disorder model. using A ATOM 1386 O ALYS 172 -5.829 1.256 -1.278 0.50 9.32 O Unresolved disorder model. using A ATOM 1387 O BLYS 172 -5.829 1.271 -1.268 0.50 9.30 O Unresolved disorder model. using A ATOM 1388 CB ALYS 172 -4.710 -0.113 -3.914 0.50 10.29 C Unresolved disorder model. using A ATOM 1389 CB BLYS 172 -4.716 -0.128 -3.885 0.50 10.27 C Unresolved disorder model. using A ATOM 1390 CG ALYS 172 -3.799 -0.409 -5.095 0.50 11.11 C Unresolved disorder model. using A ATOM 1391 CG BLYS 172 -3.674 -0.549 -4.918 0.50 11.01 C Unresolved disorder model. using A ATOM 1392 CD ALYS 172 -4.259 -1.644 -5.850 0.50 12.21 C Unresolved disorder model. using A ATOM 1393 CD BLYS 172 -3.724 0.334 -6.159 0.50 12.21 C Unresolved disorder model. using A ATOM 1394 CE ALYS 172 -3.583 -1.745 -7.205 0.50 13.69 C Unresolved disorder model. using A ATOM 1395 CE BLYS 172 -2.775 -0.166 -7.229 0.50 13.45 C Unresolved disorder model. using A ATOM 1396 NZ ALYS 172 -4.113 -2.891 -7.992 0.50 14.87 N Unresolved disorder model. using A ATOM 1397 NZ BLYS 172 -2.814 0.693 -8.444 0.50 14.45 N Unresolved disorder model. using A ATOM 1409 N AASP 175 -13.329 4.116 -3.901 0.50 11.31 N Unresolved disorder model. using A ATOM 1410 N BASP 175 -13.341 4.090 -3.909 0.50 11.02 N Unresolved disorder model. using A ATOM 1411 CA AASP 175 -14.513 4.797 -3.385 0.50 11.96 C Unresolved disorder model. using A ATOM 1412 CA BASP 175 -14.556 4.706 -3.395 0.50 11.41 C Unresolved disorder model. using A ATOM 1413 C AASP 175 -15.363 3.799 -2.597 0.50 11.81 C Unresolved disorder model. using A ATOM 1414 C BASP 175 -15.262 3.704 -2.511 0.50 11.37 C Unresolved disorder model. using A ATOM 1415 O AASP 175 -15.610 2.686 -3.063 0.50 12.46 O Unresolved disorder model. using A ATOM 1416 O BASP 175 -15.321 2.507 -2.820 0.50 11.59 O Unresolved disorder model. using A ATOM 1417 CB AASP 175 -15.328 5.415 -4.530 0.50 12.46 C Unresolved disorder model. using A ATOM 1418 CB BASP 175 -15.494 5.136 -4.526 0.50 11.64 C Unresolved disorder model. using A ATOM 1419 CG AASP 175 -14.576 6.520 -5.277 0.50 13.56 C Unresolved disorder model. using A ATOM 1420 CG BASP 175 -16.708 5.915 -4.018 0.50 12.20 C Unresolved disorder model. using A ATOM 1421 OD1AASP 175 -14.015 7.429 -4.628 0.50 15.51 O Unresolved disorder model. using A ATOM 1422 OD1BASP 175 -17.594 5.316 -3.366 0.50 12.73 O Unresolved disorder model. using A ATOM 1423 OD2AASP 175 -14.569 6.493 -6.526 0.50 15.00 O Unresolved disorder model. using A ATOM 1424 OD2BASP 175 -16.780 7.132 -4.277 0.50 13.42 O Unresolved disorder model. using A ATOM 1745 CA APRO 215 -18.639 -11.371 19.027 0.50 6.79 C Unresolved disorder model. using A ATOM 1746 CA BPRO 215 -18.642 -11.360 19.027 0.50 6.90 C Unresolved disorder model. using A ATOM 1749 CB APRO 215 -17.895 -12.705 18.994 0.50 6.90 C Unresolved disorder model. using A ATOM 1750 CB BPRO 215 -17.854 -12.678 18.987 0.50 7.07 C Unresolved disorder model. using A ATOM 1751 CG APRO 215 -18.754 -13.612 19.798 0.50 6.93 C Unresolved disorder model. using A ATOM 1752 CG BPRO 215 -17.917 -13.229 20.382 0.50 7.76 C Unresolved disorder model. using A ATOM 1753 CD APRO 215 -19.256 -12.749 20.928 0.50 7.20 C Unresolved disorder model. using A ATOM 1754 CD BPRO 215 -19.197 -12.733 20.942 0.50 7.32 C Unresolved disorder model. using A ATOM 1764 CA ASER 217 -20.029 -14.173 13.283 0.50 7.77 C Unresolved disorder model. using A ATOM 1765 CA BSER 217 -20.019 -14.170 13.295 0.50 8.00 C Unresolved disorder model. using A ATOM 1768 CB ASER 217 -21.134 -15.225 13.319 0.50 8.55 C Unresolved disorder model. using A ATOM 1769 CB BSER 217 -21.101 -15.244 13.387 0.50 8.89 C Unresolved disorder model. using A ATOM 1770 OG ASER 217 -21.177 -15.873 14.572 0.50 9.01 O Unresolved disorder model. using A ATOM 1771 OG BSER 217 -20.819 -16.328 12.525 0.50 10.78 O Unresolved disorder model. using A ATOM 1786 CA ASER 220 -14.894 -18.714 6.557 0.50 8.73 C Unresolved disorder model. using A ATOM 1787 CA BSER 220 -14.904 -18.734 6.543 0.50 9.04 C Unresolved disorder model. using A ATOM 1790 CB ASER 220 -14.736 -20.234 6.478 0.50 9.10 C Unresolved disorder model. using A ATOM 1791 CB BSER 220 -14.812 -20.252 6.396 0.50 9.54 C Unresolved disorder model. using A ATOM 1792 OG ASER 220 -15.710 -20.806 5.624 0.50 8.71 O Unresolved disorder model. using A ATOM 1793 OG BSER 220 -13.481 -20.652 6.137 0.50 10.95 O Unresolved disorder model. using A ATOM 2017 N APRO 247 0.227 -8.945 20.099 0.50 6.78 N Unresolved disorder model. using A ATOM 2018 N BPRO 247 0.226 -8.921 20.121 0.50 6.86 N Unresolved disorder model. using A ATOM 2019 CA APRO 247 -0.120 -9.760 21.263 0.50 7.19 C Unresolved disorder model. using A ATOM 2020 CA BPRO 247 -0.260 -9.763 21.203 0.50 7.27 C Unresolved disorder model. using A ATOM 2021 C APRO 247 -0.549 -8.944 22.483 0.50 7.32 C Unresolved disorder model. using A ATOM 2022 C BPRO 247 -0.550 -8.962 22.474 0.50 7.38 C Unresolved disorder model. using A ATOM 2023 O APRO 247 -0.263 -7.745 22.574 0.50 7.09 O Unresolved disorder model. using A ATOM 2024 O BPRO 247 -0.171 -7.791 22.588 0.50 7.20 O Unresolved disorder model. using A ATOM 2025 CB APRO 247 1.192 -10.490 21.581 0.50 7.40 C Unresolved disorder model. using A ATOM 2026 CB BPRO 247 0.898 -10.736 21.428 0.50 7.47 C Unresolved disorder model. using A ATOM 2027 CG APRO 247 1.933 -10.503 20.310 0.50 7.27 C Unresolved disorder model. using A ATOM 2028 CG BPRO 247 2.104 -9.954 21.050 0.50 7.65 C Unresolved disorder model. using A ATOM 2029 CD APRO 247 1.621 -9.182 19.681 0.50 7.01 C Unresolved disorder model. using A ATOM 2030 CD BPRO 247 1.674 -9.096 19.895 0.50 7.12 C Chain identifier should be blank not A: ATOM 2137 ZN ZN A 556 -6.720 -1.689 15.360 1.00 5.53 ZN 1